Clinics in Dermatology
Volume 26, Issue 1 , Pages 16-26 , January 2008

The skin in the gym: a comprehensive review of the cutaneous manifestations of community-acquired methicillin-resistant Staphylococcus aureus infection in athletes

References 

  1. Cohen PR, Grossman ME. Management of cutaneous lesions associated with an emerging epidemic: community-acquired methicillin-resistant Staphylococcus aureus skin infections. [Commentary] J Am Acad Dermatol. 2004;51:132–135
  2. Young DM, Harris HW, Charlebois ED, et al. An epidemic of methicillin-resistant Staphylococcus aureus soft tissue infections among medically underserved patients. Arch Surg. 2004;139:947–953
  3. Chambers HF. Community-associated MRSA-resistance and virulence converge. [editorial] N Engl J Med. 2005;352:1485–1487
  4. Crawford SE, Daum RS. Epidemic community-associated methicillin-resistant Staphylococcus aureus. Modern times for an ancient pathogen. Pediatr Infect Dis J. 2005;24:459–460
  5. Purcell K, Fergie J. Epidemic of community-acquired methicillin-resistant Staphylococcus aureus infections. A 14-year study at Driscoll children's hospital. Arch Pediatr Adolesc Med. 2005;159:980–985
  6. Gosbell IB. Epidemiology, clinical features and management of infections due to community methicillin-resistant Staphylococcus aureus (cMRSA). Intern Med J. 2005;35:S120–S135
  7. Kowalski TJ, Berbari EF, Osmon DR. Epidemiology, treatment, and prevention of community-acquired methicillin-resistant Staphylococcus aureus infections. Mayo Clin Proc. 2005;80:1201–1208
  8. Weber JT. Community-associated methicillin-resistant Staphylococcus aureus. Clin Infect Dis. 2005;41:S269–S272
  9. Beilman GJ, Sandifer G, Skarda D, et al. Emerging infections with community-associated methicillin-resistant Staphylococcus aureus in outpatients at an army community hospital. Surg Infect. 2005;6:87–92
  10. Elston DM. Optimal antibacterial treatment of uncomplicated skin and skin structure infections: applying a novel treatment algorithm. J Drugs Dermatol. 2005;4:s15–s19
  11. Maltin LJ. Share and share alike—except in locker room. WebMD with AOL Health. [Accessed 06 September 2004]. Available from http://aolsvc.health.webmd.aol.com/content/article/36/1676_52814.htm2004;
  12. Centers for Disease Control and Prevention . Methicillin-resistant Staphylococcus aureus infections among competitive sports participants—Colorado, Indiana, Pennsylvania, and Los Angeles county, 2000-2003. MMWR Morb Mortal Wkly Rep. 2003;52:793–795
  13. Cohen PR, Kurzrock R. Community-acquired methicillin-resistant Staphylococcus aureus skin infection: an emerging clinical problem. J Am Acad Dermatol. 2004;50:277–280
  14. Cohen PR. Cutaneous community-acquired methicillin-resistant Staphylococcus aureus infection in participants of athletic activities. South Med J. 2005;98:596–602
  15. Centers for Disease Control and Prevention . Outbreaks of community-associated methicillin-resistant Staphylococcus aureus skin infections—Los Angeles county, California, 2002-2003. MMWR Morb Mortal Wkly Rep. 2003;52:88
  16. Nguyen DM, Mascola L, Bancroft E. Recurring methicillin-resistant Staphylococcus aureus infections in a football team. Emerg Infect Dis. 2005;11:526–5322005 Apr [Accessed 14 November 2007]. Available from http://www.cdc.gov/ncidod/EID/vol11no04/04-1094.htm
  17. Arlinghaus E, Hann MJ, Nguyen A-D. Community acquired methicillin resistant Staphylococcus aureus in an athletic environment. Case Poster Presentation [Accessed 14 November 2007]. Available from http://www1.ncaa.org/membership/ed_outreach/health-safety/healthcare/sports_med_education/MRSAposter.pdf2004;
  18. Begier EM, Frenette K, Barrett NL, et al. A high-morbidity outbreak of methicillin-resistant Staphylococcus aureus among players on a college football team, facilitated by cosmetic body shaving and turf burns. Clin Infect Dis. 2004;39:1446–1453
  19. Schindehette S, Morehouse M, Erwin S. Killer microbe. People. 2005;63:133–134
  20. Mihoces G. Sports teams warned about unique skin infection. USA Today. 2003;[Accessed 22 December 2005]. Available from http://www.usatoday.com/sports/2003-10-14-sports-infections_x.htm
  21. Blauvelt H. High school team hit with MRSA. [online] USA Today. 2003;[Accessed 14 November 2007]. Available from http://www.usatoday.com/sports/preps/football/2003-10-15-skin-disease_x.htm
  22. Dominguez TJ. It's not a spider bite, it's community-acquired methicillin-resistant Staphylococcus aureus. J Am Board Fam Pract. 2004;17:220–226
  23. Rihn JA, Posfay-Barbe K, Harner CD, et al. Community-acquired methicillin-resistant Staphylococcus aureus outbreak in a local high school football team unsuccessful interventions. Pediatr Infect Dis J. 2005;24:841–843
  24. Borchardt SM, Yoder JS, Dworkin MS. Is the recent emergence of community-associated methicillin-resistant Staphylococcus aureus among participants in competitive sports limited to participants?. [letter] Clin Infect Dis. 2004;40:906–907
  25. Srinivasan A, Kazakova S. The bigger they are, the harder they fall: methicillin-resistant Staphylococcus aureus skin and soft tissue infections among professional football players—2003. [abstract #383] In: Presented at the 14th Annual Scientific Meeting of the Society for Healthcare Epidemiology of America; Philadelphia, Pennsylvania; Apr 17-20. 2004;
  26. Kazakova SV, Hageman JC, Matava M, et al. A clone of methicillin-resistant Staphylococcus aureus among professional football players. N Engl J Med. 2005;352:468–475
  27. Lindenmayer JM, Schoenfeld S, O'Grady R, Carney JK. Methicillin-resistant Staphylococcus aureus in a high school wrestling team and the surrounding community. Arch Intern Med. 1998;158:895–898
  28. Stacey AR, Endersby KE, Chan PC, Marples RR. An outbreak of methicillin resistant Staphylococcus aureus infection in a rugby football team. Br J Sports Med. 1998;32:153–154
  29. Takizawa Y, Taneike I, Nakagawa S, et al. A Panton-Valentine leucocidin (PVL)–positive community-acquired methicillin-resistant Staphylococcus aureus (MRSA) strain, another such strain carrying a multiple-drug resistance plasmid, and other more-typical PVL-negative MRSA strains found in Japan. J Clin Microbiol. 2005;43:3356–3363
  30. Goodman RA, Thacker SB, Solomon SL, Osterholm MT, Hhughes JM. Infectious diseases in competitive sports. JAMA. 1994;271:862–867
  31. Cohen PR. Community-acquired methicillin-resistant Staphylococcus aureus skin infection presenting as an axillary abscess with cellulitis in a college athlete. SKINmed: Dermatology for the Clinician. 2005;4:115–118
  32. Cohen PR. What caused this abscess and cellulitis? Diagnosis: community-acquired methicillin-resistant Staphylococcus aureus (CAMRSA) skin infection. Skin & Aging. 2004;12:56–58
  33. Cohen PR. Enlarging facial abscess with cellulitis (community-acquired methicillin-resistant Staphylococcus aureus [Dermatology Dx]. Cortlandt Forum 2005;18:42,45.
  34. Cohen PR. Enlarging facial abscess with cellulitis (community-acquired methicillin-resistant Staphylococcus aureus [Dermatology Clinic]. Clin Advis 2005;8:60, 63.
  35. Cohen PR. Community-acquired methicillin-resistant Staphylococcus aureus skin infection presenting as a periumbilical folliculitis: case reports. Cutis. 2006;77:229–232
  36. Fagan SP, Berger DH, Rahwan K, Awad SS. Spider bites presenting with methicillin-resistant Staphylococcus aureus soft tissue infection require early aggressive treatment. Surg Infect. 2003;4:311–315
  37. Miller LG, Spellberg B. Spider bites and infections caused by community-associated methicillin-resistant Staphylococcus aureus. [letter] Surg Infect. 2004;5:321–322
  38. Center for Disease Control and Prevention . Methicillin-resistant Staphylococcus aureus infections in correctional facilities—Georgia, California, and Texas, 2001-2003. MMWR Morb Mortal Wkly Rep. 2003;52:992–996
  39. Tripoli L, Bick J. HIV Education Prison Project (HEEP) news-spotlight: methicillin-resistant Staphylococcus aureus (MRSA). Aegis. 2003;6:[Accessed 14 November 2007]. Available from: www.aegis.com(Publications: Professional: HIV Educational Prison Project Report: 2003 Publications)
  40. Arkwright PD, Daniel TO, Sanyal D, David TJ, Patel L. Age-related prevalence and antibiotic resistance of pathogenic staphylococci and streptococci in children with infected atopic dermatitis at a single-specialty center. Arch Dermatol. 2002;138:939–941
  41. Lee MC, Rios AM, Aten MF, et al. Management and outcome of children with skin and soft tissue abscesses caused by community-acquired methicillin-resistant Staphylococcus aureus. Pediatr Infect Dis J. 2004;23:123–127
  42. Cohen PR. Empiric treatment of skin infections. Dr. Cohen responds. [letter] Clin Advis. 2006;9:11–12
  43. Rios AM, Lee MC, Hardy RD. Staphylococcal skin infections. Reply. [letter] Pediatr Infect Dis J. 2004;23:795–796
  44. Miller LG, Spellberg B. Treatment of community-associated methicillin-resistant Staphylococcus aureus skin and soft tissue infections with drainage but no antibiotic therapy. [letter] Pediatr Infect Dis J. 2004;23:795
  45. Faden H. Staphylococcal skin infections. [letter] Pediatr Infect Dis J. 2004;23:690
  46. Moran GJ, Talan DA. Community-associated methicillin-resistant Staphylococcus aureus: is it in your community and should it change practice?. [editorial] Ann Emerg Med. 2005;45:321–322
  47. Moran GJ, Amii RN, Abrahamian FM, Talan DA. Methicillin-resistant Staphylococcus aureus in community-acquired skin infections. Emerg Infect Dis. 2005;11:928–930Available from: www.cdc.gov/eid
  48. Grim SA, Rapp RP, Martin CA, Evans ME. Trimethoprim-sulfamethoxazole as a viable treatment option for infections caused by methicillin-resistant Staphylococcus aureus. Pharmacotherapy. 2005;25:253–264
  49. Kaplan SL. Treatment of community-associated methicillin-resistant Staphylococcus aureus infections. Pediatr Infect Dis J. 2005;24:457–458
  50. Ladhani S, Garbash M. Staphylococcal skin infections in children. Rational drug therapy recommendations. Paediatr Drugs. 2005;7:77–102
  51. Ellis MW, Lewis JS. Treatment approaches for community-acquired methicillin-resistant Staphylococcus aureus infections. Curr Opin Infect Dis. 2005;18:496–501
  52. Ruhe JJ, Monson T, Bradsher RW, Menon A. Use of long-acting tetracyclines for methicillin-resistant Staphylococcus aureus infections: case series and review of the literature. Clin Infect Dis. 2005;40:1429–1434
  53. Rybak MJ, LaPlante KL. Community-associated methicillin-resistant Staphylococcus aureus: a review. Pharmacotherapy. 2005;25:74–85
  54. Bradley JS. Newer antistaphylococcal agents. Curr Opin Pediatr. 2005;17:71–77
  55. Ashourian N, Cohen PR. Systemic antibacterial agents (Chapter 4). In:  Wolverton SE editors. Comprehensive dermatologic drug therapy. 2nd edition. Philadelphia, PA: WB Saunders Company; 2007;p. 39–74
  56. Zafar AB, Butler RC, Reese DJ, Gaydos LA, Mennonna PA. Use of 0.3% triclosan (Bacti-Stat*) to eradicate an outbreak of methicillin-resistant Staphylococcus aureus in a neonatal nursery. Am J Infect Control. 1995;23:200–208
  57. Bartzokas CA, Paton JH, Gibson MF, Graham R, McLoughlin CA, Croton RS. Control and eradication of methicillin-resistant Staphylococcus aureus on a surgical unit. N Engl J Med. 1984;311:1422–1425
  58. Dryden MS, Dailly S, Crouch M. A randomized, controlled trial of tea tree topical preparations versus a standard topical regimen for the clearance of MRSA colonization. J Hosp Infect. 2004;56:283–286
  59. Texas Department of State Health Services, Infection Disease Control Unit . Information on staphylococcal infections for school athletic departments. [Accessed 14 November 2007]. Available from: http://www.dshs.state.tx.us/idcu/health/antibiotic_resistance/mrsa/
  60. Jones RS. Expert advice on erasing the MRSA threat. Pract Dermatol. 2005;2:33–37
  61. Cohen PR. Community-acquired methicillin-resistant Staphylococcus aureus skin infections: implications for patients and practitioners. Am J Clin Dermatol. 2007;8:259–270
  62. Centers for Disease Control and Prevention . CDC suggests prevention measures for community-acquired MRSA infection. [Accessed 14 November 2007]. Available from: http://www1.ncaa.org/membership/ed_outreach/health-safety/healthcare/sports_med_education/CDC_preventionmeasures.pdf
  63. Howe WB. Preventing infectious disease in sports. Phys Sportsmed. 2003;31:Available from: http://www.physsportsmed.com/issues/2003/0203/howe.htm
  64. Rieger D, Bick J. HIV Education Prison Project (HEEP) report-spotlight: so your facility has CA-MRSA. The body: the complete HIV/AIDS. Resource. 2004;7:[Accessed 14 April 2005]. Available from: http://www.thebody.com/hepp/julaug04/spotlight.html
  65. Cohen PR. Cutaneous community-acquired methicillin-resistant Staphylococcus aureus infection: a personal perspective of a world-wide epidemic. [editorial] Expert Rev Dermatol. 2006;1:631–637http://www.future-drugs.com/doi/pdf/10.1586/17469872.1.5.631
  66. Cohen PR. Community-acquired methicillin-resistant Staphylococcus aureus skin infection: a review of epidemiology, clinical features, management, and prevention. Int J Dermatol. 2007;46:1–11

PII: S0738-081X(07)00211-8

doi: 10.1016/j.clindermatol.2007.10.006

Clinics in Dermatology
Volume 26, Issue 1 , Pages 16-26 , January 2008

Article Tools

* Image Usage & Resolution